Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsArgenx announced that Japan’s Ministry of Health, Labour and Welfare approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy.
[Argenx]
Home Newsletters Human Immunology News Argenx Announces Approval of VYVDURA (Efgartigimod Alfa and Hyaluronidase-Qvfc) in Japan for...
